Timothy Hoey, SVP, Cancer Biology at OncoMed Pharmaceuticals Inc (OMED), sold 2,500 shares at $26.41 ($66K) on 2014-05-05, disclosed to the SEC on 2014-05-07.
Scheduled sale ($66k) by SVP, Cancer Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |